379 related articles for article (PubMed ID: 11190849)
1. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
Cruz CS; Cruz LS; Domingues GS; Souza CA
Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
[TBL] [Abstract][Full Text] [Related]
4. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Bauersachs J; Fraccarollo D
Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
[TBL] [Abstract][Full Text] [Related]
6. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
Erden I; Yalcin S; Ozhan H
Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
[TBL] [Abstract][Full Text] [Related]
7. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
Diercks GF; Overdiek JW; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145
[TBL] [Abstract][Full Text] [Related]
8. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
Tamirisa KP; Aaronson KD; Koelling TM
Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone for heart failure.
Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
[No Abstract] [Full Text] [Related]
11. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
Gottlieb S
BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321896
[No Abstract] [Full Text] [Related]
12. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
13. [An elderly man with known heart failure admitted with cardiogenic shock].
Hovland A; Fagerheim AK; Hardersen R; Nielsen EW
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1352-4. PubMed ID: 20596117
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone and ACE inhibition in chronic renal failure.
Almirall J; Lopez T
N Engl J Med; 2002 Feb; 346(6):456-7. PubMed ID: 11837270
[No Abstract] [Full Text] [Related]
15. Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort.
Abbas S; Ihle P; Harder S; Schubert I
Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):406-13. PubMed ID: 25683504
[TBL] [Abstract][Full Text] [Related]
16. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
[TBL] [Abstract][Full Text] [Related]
17. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
[TBL] [Abstract][Full Text] [Related]
18. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
Konopa J; Bułło B; Rutkowski B
Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
[TBL] [Abstract][Full Text] [Related]
19. [Hyperkalemia, heart failure and reduced renal function].
Bugge JF
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1354-5. PubMed ID: 20596118
[No Abstract] [Full Text] [Related]
20. Spironolactone in patients with heart failure.
Vanpee D; Swine C
N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
